Dynavax Technologies Corp Files 8-K on Officer/Director Changes
| Field | Detail |
|---|---|
| Company | Dynavax Technologies Corp |
| Form Type | 8-K |
| Filed Date | Oct 16, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
Related Tickers: DVAX
TL;DR
Dynavax 8-K: Leadership changes happening, details to follow.
AI Summary
Dynavax Technologies Corporation filed an 8-K on October 16, 2025, reporting events as of October 15, 2025. The filing pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. Specific details regarding these changes were not provided in the excerpt.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: low — The filing is procedural and reports on standard corporate governance events without immediate financial implications.
Key Numbers
- 001-34207 — SEC File Number (Identifies the company's filing with the SEC.)
- 33-0728374 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Dynavax Technologies Corporation (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- 2100 Powell Street, Suite 720, Emeryville, CA 94608 (address) — Principal Executive Offices
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates the departure of directors or certain officers, election of directors, and appointment of certain officers, but the specific names and details are not provided in this excerpt.
What is the date of the earliest event reported in this 8-K?
The date of the earliest event reported is October 15, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on October 16, 2025.
What is Dynavax Technologies Corporation's principal executive office address?
The principal executive offices are located at 2100 Powell Street, Suite 720, Emeryville, CA 94608.
What are the key items covered in this 8-K filing?
The key items covered are the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
Filing Stats: 503 words · 2 min read · ~2 pages · Grade level 14.1 · Accepted 2025-10-16 06:01:52
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value DVAX Nasdaq Global Select
Filing Documents
- d40644d8k.htm (8-K) — 23KB
- 0001193125-25-240766.txt ( ) — 133KB
- dvax-20251015.xsd (EX-101.SCH) — 3KB
- dvax-20251015_lab.xml (EX-101.LAB) — 18KB
- dvax-20251015_pre.xml (EX-101.PRE) — 11KB
- d40644d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Dynavax Technologies Corporation Date: October 15, 2025 By: /s/ John Slebir John Slebir Senior Vice President, General Counsel